International Womens Health, Reproductive Medicine Events,Fertility Meetings, CME conference, CPD meeting

Recommended Global Reproductive Medicine & Women Healthcare Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

REPRODUCTION FERTILITY 2025

About Conference

The “7^th International Conference on Women’s Health, Reproduction and Fertility" is being hosted by Conference Series and scheduled to be held on November 19-20, 2025. The "Theme: "Reproductive Health and Fertility Preservation: Addressing Modern Challenges" that provides a programed to discuss about Reproductive Life will be the main topic of this REPRODUCTION FERTILITY 2025 Conference.

The main goal of REPRODUCTION FERTILITY 2025 is to give medical professionals, educators, medical directors, gynecological oncologists, and other healthcare workers a platform for discussion and idea exchange on a global scale. This platform will feature timely keynote addresses, oral presentations, poster presentations, video presentations and exhibitions, symposiums, workshops, and a young researchers' forum on the most recent treatments and contraceptive methods.

Why to attend?

At the 7th International Conference on Women’s Health, Reproduction and Fertility where the organizing committee is preparing for an exciting and educational reproductive conference programme including plenary lectures, symposia, workshops on a variety of topics, poster presentations, and various programs, leading scientists, researchers, professionals, and exhibitors from all over the world are gathering.

It's time to seize the chance to participate in REPRODUCTION FERTILITY 2025 as a delegate, in a panel discussion, with speakers, with posters, with video proposals, in business meetings, with networking opportunities, and with additional perks for our event sponsor. The conference's most cutting-edge methods, improvements, sharing of fresh concepts, and research updates in women's health, fertility, and related advancements are its telltale indications.

Target Audience:

Obstetrics and Gynecologists
Specialists in IVF
IVF Centers
Gynecological Pathologists
Gynecological Oncologists
Directors of Maternity Hospitals
Endocrinologists
Infertility specialists
Heads of the Obstetrics & Gynecology Departments
Pharmacotherapists
Nursing scholars
Psychologists
Students of Medicine Disciplines
Upcoming Researcher
Pharmacists
Anesthesiologist
Family Medicine Physicians and General practitioners
Pharmacologists
Health care systems and Hospitals
Clinical Toxicologists
IVF Associations and Societies
Societies of Andrology and Gynecology
Obstetrics Community
Health Care Professionals

Sessions & Tracks

Track 1: Importance of Women’s Health

The treatment and diagnosis of diseases and ailments that affect women's physical and emotional well-being is the focus of the medical specialty known as women's health. In general, women and men have similar health problems; the only difference is that women's health needs to be specifically taken into account. Young women's health issues, adolescence, pregnancy, and delivery are all biological processes. Women's health is significant because they have unique healthcare needs and have a higher likelihood than men of receiving a diagnosis for a certain condition. Chronic conditions like diabetes, heart disease, cancer, and diabetes are among the leading causes of death in women. The intriguing health conditions that affect women include menopause, abnormalities of the female organs, and pregnancy. The two medical procedures that pose the greatest health hazards to young women between the ages of 15 and 19 are becoming pregnant and giving birth.

Chronic diseases
Heart disease
Diabetes

World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG)

Track 2: Reproductive Technologies and Precision Medicine

This track explores cutting-edge advancements in assisted reproductive technologies (ART) and precision medicine. From IVF and hormonal therapies to genetic screening and AI-based fertility prediction, these innovations are transforming fertility care. Topics include infectious disease risks, disorders of sex development, and ethical concerns in reproductive interventions. Emphasis is placed on personalized treatments and digital tools that enhance reproductive outcomes.

Key Topics:

IVF, ICSI, and cryopreservation
Genetic screening and counseling
AI in fertility prediction
Digital biomarkers and wearables
Medico legal issues

European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI)

Track 3: Stem Cells and Regenerative Medicine

Stem cells are undifferentiated cells having the ability to self-replicate and specialize into distinct cell types. The two main properties of stem cells are self-renewal and potency, which allow them to differentiate into any form of cell. Ovaries do contain stem cells that develop into oocytes in adults and can be created in vitro to produce children, according to studies published offered novel validation of the endometrial healing caused by stem cells in patients who had bone marrow transplants. It is feasible to use this research to treat uterine issues. Regenerative medicine is opening new avenues in reproductive health through stem cell technologies. This track explores tissue repair, regeneration, and restoration of reproductive capacity.

Infections
Reproductive tract infection
Ovarian and endometrial stem cell therapy
Uterine bioengineering
Germ cell development from stem cells
Regenerative applications in reproductive surgery

American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS)

Track 4: Fertility & Infertility

Fertility is the capacity to conceive and bear children. It is influenced by multiple factors such as age, lifestyle, hormones, genetics, and underlying health conditions. The most fertile period is during ovulation, typically between days 11–21 of the menstrual cycle. Age-related fertility decline, obesity, and disorders like Postmenopausal girls, PCOS and endometriosis are common challenges. Key causes of infertility include:

Polycystic ovarian syndrome
Endometriosis
Tubal blockages
Advanced maternal age
Female fertility
Low egg quantity and quality
Male factor infertility

Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA)

Track 5: Fertility Surgery and IVF Treatment

Sterility in men is treated with

Surgery, if the cause is a varicocele( widening of the modes in the scrotum) or a vas deferens inhibition.
Antibiotics to clean up impurity in the genitalia.
Drug and comforting to treat construction or interjection problems.
Hormone curatives if a hormone imbalance is the cause of the issue.

Sterility in women is treated with

Fertility medicines and hormones to help in reestablishing hormone situations and induce ovulation in the case.
Surgery to open dammed fallopian tubes or remove towel that's precluding fertility

In vitro fertilization is a type of supported reproductive technology used to treat gravidity. In IVF, sperm and an egg are fertilized in a liquid media outside of the body.

American College of Obstetricians and Gynecologists (ACOG) | Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO)

Track 6: Obstetrics, Gynecology, and Maternal Care

This track provides a comprehensive overview of women’s reproductive health across the life span, with a particular emphasis on pregnancy and childbirth. Obstetrics ensures the safety of mother and child before, during, and after delivery, while gynecology focuses on diagnosing and treating conditions related to the female reproductive system. It also addresses common gynecologic concerns such as fibroids and uterine anomalies, as well as challenges like malignant tumors and pelvic inflammatory disease.

Key Topics:

Prenatal care and fetal monitoring
Cesarean section and labor induction
Maternal care and postnatal wellness
Menstrual disorders and menopause
Malignant tumors and reproductive diagnostics

Track 7: Drug Management during Pregnancy

Drugs are commonly used to correct various anomalies during pregnancy. Drugs are often used to treat illnesses during pregnancy when the potential benefits outweigh the known hazards. The most frequently given drugs include antibiotics, analgesics, antihistamines, antiemetics, and tranquillizers. The growth and development of the foetus may be impacted by drug use later in pregnancy. Drugs that may have an impact on foetal development include angiotensin, antithyroid medications, benzodiazepines, blockers, and other medications. But in the UK, every single pregnant woman receives at least one course of medication treatment advice (no less than 33%).

Tranquillizers
Antihistamines
Antiemetic’s
Analgesics
Antibiotics

Track 8: Obstetric Analgesia and Anesthesia

Peripartum analgesia for labor and anesthesia for caesarean deliveries are provided by the anesthesia subspecialty known as obstetric anesthesia, often known as ob-gyn anesthesia or ob-gyn anesthesiology. For the attending anesthesiologists, it has always been challenging to give anesthesia during pregnancy for both obstetric and non-obstetric surgery. While a substantial percentage of an obstetric anesthesiologist's practice may involve directing anesthesia for caesarean sections and managing pain during vaginal deliveries, the specialty is increasingly growing to include anesthesia for both maternal and foetal operations. When labour pains are present, obstetric anesthetists are commonly called upon. Buprenorphine is the medication that is most usually used to produce a more pronounced physical square.

Obstetric anesthesia
Obstetric Anesthesiology

Track 9: Adolescent and Maternal Health

Human development is sensitive during the teenage years. It represents the passage from childhood to actual and intellectual adulthood. The Sub-Saharan region has the largest incidence of early childbearing practices, with birth rates among teens exceeding 200 per 1,000 women between the ages of 15 and 19. The Central African Republic, Niger, Chad, Angola, and Mali (with a rate of teenage births above 180) are the countries with the highest rates of teenage births. Maternal health is the condition of women prior to, during, and following childbirth. Healthcare for family planning, conception, pregnancy, labour, and delivery is all included. Discharge, unsafe abortions, and labour obstruction are the leading causes of maternal morbidity and mortality.

Maternal morbidity and mortality
Maternal Health

Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM)

Track 10: Polycystic Ovary Syndrome

PCOS is a common hormonal disorder that affects women who are fertile. It is a collection of symptoms brought on by females' increased androgen levels. Heavy periods, irregular or non existent menstrual cycles, excessive body and facial hair, acne, pelvic pain, difficulties getting pregnant, and areas of thick, darker, smoother skin are some of the signs and symptoms of PCOS. Both inherited and environmental factors contribute to it. It's past cure. Birth control pills may benefit acne, excessive hair growth, and regular menstrual cycles. Metformin and anti-androgens may also be beneficial. Weight loss, the use of metformin, and clomiphene are all methods to boost fertility. In vitro fertilization is another technique used. It is the endocrine disorder that affects women the most commonly between the ages of 18 and facial hair

Excessive body
Heavy periods
Acne
Pelvic pain

Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE)

Track 11: Sexually Transmitted Infections

Sexually transmitted infections are illnesses that are spread by sexual contact, including anal, oral, and vaginal sex. The symptoms of this condition include pelvic pain, ulcers on or around the genitalia, vaginal discharge, penile discharge, and ulcers. The three groups include bacterial infections, viral STIs, and parasitic STIs. Among the bacterial infections are gonorrhoea, chlamydia, and syphilis. Viral diseases include genital herpes, genital warts, and HIV/AIDS. An illustration is the parasitic STI trichomoniasis. Less dangerous sexual activities are employed. In the classroom, thorough sex education is also advantageous.

Pelvic pain
Vaginal discharge
Penile discharge
HIV/AIDS

Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO) | International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE)

Track 12: Female Reproductive Cancer

Reproductive malignancies are brought on by the unchecked growth and multiplication of abnormal cells that arise in the reproductive organs. Gynaecologic tumours in women are often found in the United States. 91,730 new cases are estimated to be investigated in the United States this year alone; tragically, 28,080 deaths are anticipated. The most common treatments for reproductive cancers include chemotherapy, surgery, radiation therapy, hormone therapy, or a combination of these.

Cancer of the uterus
Ovarian cancer
Regular pelvic examinations

International Federation of Gynecology and Obstetrics (FIGO) | American Society for Reproductive Medicine (ASRM) | European Society of Human Reproduction and Embryology (ESHRE) | Asia Pacific Initiative on Reproduction (ASPIRE) | American College of Obstetricians and Gynecologists (ACOG)

Track 13: Reproductive Endocrinology

Reproductive endocrinology is the study of hormonal function and dysfunction across a woman's reproductive lifespan from adolescence to menopause. It encompasses the regulation of fertility, menstrual health, gametogenesis, and embryonic development through complex interactions between the pituitary, ovaries, and other endocrine glands. This track also investigates endocrine disorders that impact fertility and the role of reproductive medicine and assisted technologies like IVF in restoring hormonal balance and reproductive capacity.

Key Topics:

Hypothalamic-pituitary-ovarian axis dysfunction
Hormonal regulation and fertility evaluation
Endocrine-related causes of infertility (e.g., PCOS, endometriosis)
Ovulation induction and hormonal therapy
In vitro fertilization and reproductive hormone control
Male reproductive endocrinology
Gynecological endocrine disorders hormones

Track 14: Neuroendocrinology of Reproduction

This track focuses on the neuroendocrine mechanisms that influence reproduction by integrating brain function with hormonal signals. It highlights how neural control affects the hypothalamus-pituitary-gonadal axis and how stress, neurotransmitters, and brain aging impact reproductive health, psychological and behavior.

Key Topics:

GnRH pulse regulation and hypothalamic signaling
Neurotransmitters in reproductive physiology
Stress, amenorrhea, and ovulation suppression
Neuroendocrinology control of puberty and menopause
Brain–reproductive system interaction and behavioral aspects
Neurological changes during reproductive transitions

Canadian Fertility & Andrology Society (CFAS) | Middle East Fertility Society (MEFS) | Women’s Global Health Imperative (WGHI) | Latin American Network for Reproductive Medicine (REDLARA) | World Health Organization (WHO)

Track 15: Mental Health in Reproductive and Perinatal Life Stages

Emotional and psychological well-being is vital across all stages of reproductive life from preconception and fertility treatments to pregnancy, postpartum recovery, and menopause. This track explores how reproductive events can influence mental health, highlighting conditions such as depression, anxiety, and perinatal mood disorders. It emphasizes the importance of early screening, integrated mental health care, and supportive counseling to improve outcomes for both mothers and families. Special focus is placed on the

Psychological effects of infertility and miscarriage
Postpartum depression and perinatal anxiety disorders
Stress and IVF outcomes
Mental health integration into fertility and maternal care
Counseling, peer support, and therapeutic interventions
Mood and cognitive changes during menopause

Track 16: Menopause and Healthy Aging in Women

Menopause marks a significant hormonal and physiological transition in a woman's life, often accompanied by symptoms that impact physical and emotional well-being. This track explores the multifaceted effects of menopause and offers evidence-based strategies to support healthy aging and improve quality of life.

Key Topics:

Hormone replacement therapy (HRT)
Menopausal symptom management
Bone and cardiovascular health
Cognitive wellness and aging
Lifestyle approaches for healthy aging

Track 17: Male Factor in Reproductive Medicine

Male reproductive health is essential to fertility outcomes. This track covers diagnostics, treatment, and innovations.

• Semen analysis and DNA fragmentation
• Varicocele management and surgery
• Hormonal therapy for male infertility
• Male fertility preservation techniques
• Environmental and lifestyle impacts

Track 18: Microbiome in Women’s Health and Fertility

The human microbiome is a crucial but often overlooked factor in reproductive wellness. This track explores microbiota in relation to fertility, pregnancy, and gynecological health.

• Vaginal microbiome and infection resistance

• Gut microbiota's impact on estrogen metabolism

• Microbiome and IVF outcomes

• Dysbiosis and miscarriage

• Probiotics and therapeutic modulation

Track 19: Reproductive Immunology and Implantation Science

This track delves into how immune responses affect fertility, embryo implantation, and pregnancy outcomes. It covers immune tolerance, inflammation, and recurrent implantation failure.

Key Topics:

Maternal immune tolerance
Immunological causes of infertility
Recurrent implantation failure
Immune modulation in IVF
Cytokines and endometrial receptivity

Participation Benefits

Benefits of Participation for Speaker

Worldwide appreciation of the profile of Researchers.
Obtain credits for professional growth.
Explore the latest cutting-edge analysis.
Make long-term bonds at social and networking activities.
An ability to advertise one page in the distribution of abstract books and flyers that ultimately gets 1 million views and adds great value to your research profile.
Learn a transition beyond your area of interest to learn more about new subjects and studies away from your core subject of Women Health.
We have distinctive networking, learning, and enjoyable integration into a single package.

Benefits of Participation for Delegate

Professional Development-Improve understanding and knowledge.
Attendance at webinars supports, rejuvenates, and energizes delegates.
Your involvement in our webinar will help with a new methodology and ideology that can be used to broaden the outcomes of businesses or industries.
Opportunities for researchers and experts in the same field to meet and exchange new ideas through an online webinar.

Benefit of Participation for Sponsor

Exposure to the international environment would increase the possibility of new companies.
Opportunity to demonstrate your company's latest technologies, new products, or service your business to a wide range of international participants.
Increase business by our participants through lead generation.
It takes a lot of time, effort, and drive to create a successful company, so it's always nice to have a network of colleagues and associates to draw energy from individuals who share a common drive and objective.
Webinars provide opportunities for more attention and contemplation that could help you move your company to the next stage.
Benchmarking main organization plans and moving them forward.
Get feedback from trustworthy people at our webinar to your company questions and challenges.
On our webinar banner, website, and other proceedings, branding, and marketing content, the advertising logo of your company.

Benefit of the Association for Collaborators

In our webinar banner, website and other proceedings, branding and marketing material, promotional content and your Organization logo will increase your number of subscribers/members by 40%.
The exposure of our event to your Company listing in the Global Business forum will have a great effect on your association.
Your representatives can network to update their knowledge and understanding of your organization and services with key webinar delegates.
Advertising materials such as posters, brochures, pamphlets, and services that will be circulated to hospitals, universities, society, and researchers will be integrated with information.

Market Analysis

Scope and Importance:

The main thing of statistical surveying is to increase public mindfulness of issues relating to reproductive systems and to identify the request terrain for reproductive health as well as critical improvements. The council/ conversations at this conference will concentrate on reproductive health. This meeting is intended to give detailed information about the different approaches used to treat gynecological cancers, gravidity, PCOS, sexually transmitted infections, etc.

Women’s Health Market:

In 2010, there were 6.15 billion people on the planet, 49.7% of whom were women. By 2025, a similar trend is anticipated to be in place. There will be 8.19 billion people on the planet by 2025, 49.5% of whom will be female. This calculated number explains the Women's Health showcase's growth potential through 2025. When compared to males, women typically outlive them and undergo quicker hormonal, physical, and emotional changes over their lifetime. This aspect is currently acting as a catalyst for providing women in all nations with better medical and educational services.

With a compound annual growth rate (CAGR) of 4.2% from 2015 to 2020, the global market for women's well-being pharmaceuticals will expand from over $33.0 billion in 2015 to almost $40.6 billion by that year. The global market for women's healthcare is expected to reach USD 5.13 billion by 2025, according to sophisticated study on the subject.Various independent research agencies estimated that the global market for women's health was worth 30.88 billion in 2016 and predicted that it would grow to more than 51.3 billion by 2025 at a CAGR of 5.85%.

Fertility Services Market:

Services related to fertility include special methods for addressing genetic and reproductive problems as well as aiding in conception. These services aid couples or single guardians all over the world by incorporating various ART tactics. The Global Fertility Services Market was valued at $16,761 million in 2016 and is anticipated to grow to $30,964 million by 2023, at a compound annual growth rate (CAGR) of 9.3%. The market for IVF administrations generated $10,587 million in 2017 and is projected to reach $22,467 million by 2025, growing at a CAGR of 9.8% between 2018 and 2025. At a CAGR of 4.3% from 2017 to 2022, the global market for fertility medications is expected to increase from $3.4 billion in 2017 to $4.2 billion in 2022.billion in 2013. In 2018, the anticipated incomes will probably reach $19.6 billion, showing a CAGR of 4.1%.

The global contraceptive market, which was estimated to be worth $19.8 billion in 2015, is expected to grow and reach $33.6 billion by 2023, with a CAGR growth of 6.8% during this time. The population's expanding needs, the rise in STD cases, the expansion of the need for unwelcome pregnancy prevention, and female awareness are all factors driving the growth of the contraceptive market.

Related Associations and Societies

Middle East: Middle East Fertility Society (MEFS), Syrian American Medical Society, Iranian Scientific Association of Embryology and Reproductive Biology, Iranian Scientific Association of Endocrinolog, Iranian Scientific Association of Reproductive Medicine, Turkish Society of Obstetrics and Gynecology, Turkish Society for Reproductive Medicine, Turkish Infertility Foundation, Turkish Medical Association, Iraqi Society of Obstetrics & Gynecology (ISOG), Saudi Society of Obstetrics & Gynecology, Saudi Obstetrical and Gynaecological Society, Saudi Gynecology Oncology Group

USA: American Association of Gynecologic Laparoscopists, American College of Obstetricians & Gynaecologists, The Association of Physician Assistants in Obstetrics and Gynecology, Association of Professors of Gynecology and Obstetrics, Central Association of Obstetricians and Gynecologists, Gynecologic Cancer Foundation, Society of Gynecologic Oncologists (SGO), International Urogynecological Association (IUGA), American Osteopathic Board of Obstetrics and Gynecology, American Society Reproductive Medicine

Europe: The European Society of Contraception and Reproductive Health, German Foundation for World Population, European Association of Pediatric and Adolescent Gynecology, Italian Society for Obstetrics and Gynecology, European board & college of Obstetrics and Gynaecology, European Society of Gynecological Oncology, Austrian Society of Sterility, Infertility and Endocrinology, Croatian Society for Gynecological Endoscopy, German Society of Gynecological and Obstetrical Endoscopy

Past Conference Report

Thanks to all of our amazing keynote speakers, presenters, conference attendees, students, associations, media partners, and visitors REPRODUCTION FERTILITY 2024 was a huge success. The "6th International Conference on Women's Health, Reproduction and Fertility" on August 24–25, 2024 at Frankfurt, Germany with the theme "Leading Healthy Reproductive Life" was a big success thanks to Conference Series. The audience heard from renowned keynote speakers who represented a variety of prestigious organizations and groups. Renowned experts, members of the Editorial Board of journals in the Conference series, students, research scholars, scientists, young researchers, industrialists, endocrinologists, doctors, gynecological oncologists, and student researchers all generously and actively participated and helped make the event a success. A ceremony and speeches by the Keynote forum speakers marked the beginning of the conference. The experts who spread the message with their beautiful talk were. Let's reconnect @ REPRODUCTION FERTILITY 2025

To Collaborate Scientific Professionals around the World

Conference Date November 19-20, 2025

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Supported By

Gynecology & Obstetrics Journal of Womens Health, Issues and Care Journal of Pregnancy and Child Health

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Womens Health, Reproduction and Fertility

November 19-20, 2025 Tokyo, Japan

"Reproductive Health and Fertility Preservation: Addressing Modern Challenges"

REPRODUCTION FERTILITY 2025 | Fertility Conference | Gynecology Congress | Europe | Middle East | Asia | Osaka | Japan

Conference Series Conferences gaining more Readers and Visitors

Recommended Global Reproductive Medicine & Women Healthcare Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

REPRODUCTION FERTILITY 2025

About Conference

Sessions & Tracks

Participation Benefits

Benefits of Participation for Speaker

Market Analysis

Past Conference Report

To Collaborate Scientific Professionals around the World

Useful Links

Supported By

Keytopics